Showing 31-40 of 377 results for "".
- New Officers Assume Roles with the American Academy of Dermatologyhttps://practicaldermatology.com/news/new-officers-assume-roles-with-the-american-academy-of-dermatology/2458976/Mark Lebwohl, MD, FAAD, a dermatologist in New York City, took office as president of the American Academy of Dermatology (AAD). Timothy G. Berger, MD, FAAD, a dermatologist in San Francisco, also assumed his position as vice president of the AAD. Drs. Lebwohl and Berger assumed office at the con
- Mirvaso Approved by the European Commissionhttps://practicaldermatology.com/news/20140226-mirvaso_approved_by_the_european_commission/2459330/The European Commission has granted marketing authorization in Europe for Galderma's Mirvaso (brimonidine) 3 mg/g gel. Mirvaso, an alpha-2 adrenergic receptor agonist that acts rapidly and can last for up to 12 hours, is indicated for the symptomatic tr
- Revealed: Why Skin Feels “Tight” After Using a Facial Cleanserhttps://practicaldermatology.com/news/revealed-why-skin-feels-tight-after-using-a-facial-cleanser/2462023/Some cleansers make the skin feel “tight” and some moisturizers make the skin feel “soft,” but exactly why this occurs hasn't been fully understood. To find out, Reinhold H. Dauskardt, the Ruth G. and William K. Bowes Professor in Stanford’s
DWTV Extra: DermLink Scholars Founder Dr. Kelly Frasier
https://practicaldermatology.com/videos/dermwire-tv/DWTV-Extra-DermLink-Scholars-Founder-Dr-Kelly-Frasier/36554/DermLink Scholars Founder and CEO Kelly Frasier, DO, MS, CRC, and Alina G. Bridges, DO, FAAD, discuss the organization and its inaugural virtual conference Saturday, August 2. For more information, go to dermlinkscholars.com.TOGETHER-PsO: Dual Therapy for Psoriasis and Obesity
https://practicaldermatology.com/videos/skin-minute/together-pso-dual-therapy-for-psoriasis-and-obesity/57262/Mark G. Lebwohl, MD, provides key takeaways and commentary on the results of the TOGETHER-PsO study, which looked at a combination therapy of ixekizumab (Taltz) and tirzepatide (Zepbound) in patients with both psoriasis and obesity.The Importance of Early Intervention for Psoriatic Arthritis
https://practicaldermatology.com/programs/practical-dermatology-focus-psoriasis/importance-early-intervention-psoriatic-arthritis/29076/Psoriatic arthritis continues to be one of the most common and chronic manifestations of psoriatic disease. Practical Dermatology® spoke with G. Michael Lewitt, who sits on the Medical Board of the National Psoriasis Foundation, to discuss diagnosis and treatment strategies for psoriatic arthritis.Your Destination for the Latest Developments in #Dermatology in Print and Online
https://practicaldermatology.com/topics/general-topics/your-destination-for-the-latest-developments-in-dermatology-in-print-and-online/20983/Cosmetics Challenge
https://practicaldermatology.com/topics/general-topics/cosmetics-challenge/21793/Cosmetics Challenge: Going with the Flow: An Overview and Clinical Discussion of The Rheology of Soft Tissue Fillers, Part 1 of 2
https://practicaldermatology.com/topics/general-topics/cosmetics-challenge-going-with-the-flow-an-overview-and-clinical-discussion-of-the-rheology-of-soft-tissue-fillers-part-1-of-2/21890/Flow properties and the clinical behavior that these properties predict can be important factors that help clinicians refine and individualize treatment with dermal fillers.Your MIPS 2018 Reporting Cheat Sheet
https://practicaldermatology.com/topics/practice-management/your-mips-2018-reporting-cheat-sheet/20478/Follow this advice to avoid a penalty in 2020.